VR Devices Focus Of FDA Patient Engagement Advisory Committee
The emerging technology carries benefits and risks
The US agency’s Patient Engagement Advisory Committee (PEAC) held a webinar to evaluate the benefits and risks of virtual and augmented reality medical devices, the need for patient education on the technology, and how patient perspectives can better inform the agency’s decision making in bringing these devices to market.
